Literature DB >> 25135372

Pregnancy outcomes of mothers with an alcohol-related diagnosis: a population-based cohort study for the period 1983-2007.

V M Srikartika1, C M O'Leary.   

Abstract

OBJECTIVE: To examine fetal outcomes of mothers with an alcohol-related diagnosis.
DESIGN: Population-based cohort.
SETTING: Western Australia (WA). POPULATION: Births on the WA Midwives Notification System (1983-2007).
METHODS: Infants of mothers with an alcohol-related diagnosis [International Classification of Disease (ICD), 9th/10th revisions] recorded on WA health data sets (non-Aboriginal n = 13 807; Aboriginal n = 9766) were identified through the WA data linkage system. A comparison cohort of infants born to mothers without an alcohol diagnosis was frequency matched on maternal age, year of birth of the offspring, and Aboriginal status (non-Aboriginal n = 40 148; Aboriginal n = 20 643). MAIN OUTCOME MEASURES: Poisson regression-generated adjusted relative risk (aRR) and 95% confidence intervals (95% CIs) for small for gestational age (SGA), preterm birth, and low-Apgar score, calculated separately for non-Aboriginal and Aboriginal infants of mothers with an alcohol diagnosis recorded during pregnancy and any alcohol diagnosis. Population-attributable fractions were calculated.
RESULTS: The aRR for non-Aboriginal infants when a maternal alcohol diagnosis was recorded during pregnancy ranged from 1.79 (95% CI 1.42-2.16) for SGA to 2.57 (95% CI 1.69-4.27) for preterm birth <32 weeks of gestation, and for Aboriginal infants ranged from 2.69 (95% CI 2.28-3.16) to 1.99 (95% CI 1.40-2.84), respectively. The highest population-attributable fractions were for any alcohol diagnosis and for Aboriginal infants. For Aboriginal births, approximately 9% (95% CI 4.74-12.97) and 10.1% (95% CI 5.50-14.49) of moderate and very preterm births, respectively, and 24.4% (95% CI 13.5-21.2%) of SGAs were attributable to having a mother with any alcohol-related diagnosis.
CONCLUSIONS: Mothers with an alcohol diagnosis are at increased risk of poor pregnancy outcomes. The public health impact of maternal alcohol-use disorders on fetal outcomes is significant.
© 2014 Royal College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  Alcohol and pregnancy; cohort study; data linkage; pregnancy outcomes; preterm birth; small for gestational age

Mesh:

Year:  2014        PMID: 25135372     DOI: 10.1111/1471-0528.12983

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  7 in total

1.  Obstetric and Perinatal Morbidity in Northern Tasmanian Aboriginal Population: A Retrospective Cohort Study.

Authors:  Rashida Hakeem; Amanda Dennis; Kathryn Ogden; Kiran D K Ahuja; Mohammed Abdul Hakeem
Journal:  J Clin Diagn Res       Date:  2016-05-01

Review 2.  Substance Use in the Perinatal Period.

Authors:  Ariadna Forray; Dawn Foster
Journal:  Curr Psychiatry Rep       Date:  2015-11       Impact factor: 5.285

Review 3.  Substance use in pregnancy: The medical challenge.

Authors:  Kerry-Ann Louw
Journal:  Obstet Med       Date:  2018-03-12

Review 4.  Substance use during pregnancy.

Authors:  Ariadna Forray
Journal:  F1000Res       Date:  2016-05-13

5.  PLGF, a placental marker of fetal brain defects after in utero alcohol exposure.

Authors:  Matthieu Lecuyer; Annie Laquerrière; Soumeya Bekri; Céline Lesueur; Yasmina Ramdani; Sylvie Jégou; Arnaud Uguen; Pascale Marcorelles; Stéphane Marret; Bruno J Gonzalez
Journal:  Acta Neuropathol Commun       Date:  2017-06-06       Impact factor: 7.801

6.  Drowning our sorrows: clinical and ethical considerations of termination in alcohol-affected pregnancy.

Authors:  Roger Martin; George Bruxner; Gary Ng; Catherine Brewster; Alka Kothari
Journal:  BMC Pregnancy Childbirth       Date:  2020-06-10       Impact factor: 3.007

Review 7.  Psychobiobehavioral Model for Preterm Birth in Pregnant Women in Low- and Middle-Income Countries.

Authors:  Shahirose S Premji; Ilona S Yim; Aliyah Dosani Mawji; Zeenatkhanu Kanji; Salima Sulaiman; Joseph W Musana; Pauline Samia; Kiran Shaikh; Nicole Letourneau
Journal:  Biomed Res Int       Date:  2015-08-27       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.